CENTER FOR AIDS RESEARCH (CFAR)
艾滋病研究中心 (CFAR)
基本信息
- 批准号:8357388
- 负责人:
- 金额:$ 17.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-01 至 2012-04-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcquired Immunodeficiency SyndromeBasic ScienceBehavioral ResearchBiological AssayClinical ResearchClinical VirologyConsultationsData AnalysesDevice or Instrument DevelopmentEpidemiologistEquipmentFacultyFlow CytometryFundingGene ExpressionGrantHIVHumanImmunologyIncidenceLaboratoriesNational Center for Research ResourcesPrevalencePrimary PreventionPrimatesPrincipal InvestigatorResearchResearch InfrastructureResearch PersonnelResearch SupportResourcesReverse Transcriptase Polymerase Chain ReactionSamplingSavingsSecondary PreventionServicesSourceStaining methodStainsStudy SubjectTimeTrainingTranslational ResearchUnited States National Institutes of HealthVaccinesassay developmentbasecostcytokinegraduate studentmembermen who have sex with mennonhuman primate
项目摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
The Center for AIDS Research (CFAR) at Emory facilitates scientifically rigorous basic, clinical, translational, and behavioral research in HIV/AIDS and connects HIV/AIDS researchers within and across scientific fields with the objective of increasing NIHfunded research in the primary and secondary prevention of HIV and its aftermath.
The Immunology Core, at the Emory Vaccine Center at Yerkes, produced a multicolor cytokine flow cytometry staining panel for human and non-human primate samples. The panel provides substantial resource savings for investigators, as it is quicker and requires fewer samples and materials. CFAR and EVC members, including Drs. Ahmed, Amara, Hunter, Villinger, and outside laboratories and users of the Yerkes National Primate Research Center have successfully used the panel. The CFAR Pre-Clinical Virology Core at Yerkes, provides instrument and assay development training and consultation to fellows and graduate students to facilitate and accelerate the pace of research in investigator's labs. For example, the Core provided full-service, real-time RT-PCR-based gene expression assays and data analysis assistance to Colleen Kelley (ID Fellow) who collaborated with Patrick Sullivan (epidemiologist) to expand his study "Explaining the difference in HIV prevalence and incidence between white and black men who have sex with men" (R01 MH085600). The Core's support enlarged the pool of available study subjects and brought new investigators into HIV/AIDS research.
Through the strategic use of funds, the CFAR assisted in the recruitment of leading senior and junior faculty and provided essential equipment to a number of CFAR and EVC-affiliated investigators.
该副本是利用资源的众多研究子项目之一
由NIH/NCRR资助的中心赠款提供。对该子弹的主要支持
而且,副投影的主要研究员可能是其他来源提供的
包括其他NIH来源。 列出的总费用可能
代表subproject使用的中心基础架构的估计量,
NCRR赠款不直接向子弹或副本人员提供的直接资金。
Emory的艾滋病研究中心(CFAR)促进了艾滋病毒/艾滋病的科学严格,临床,转化和行为研究,并将科学领域内和跨科学领域的艾滋病毒/艾滋病研究人员联系起来,目的是增加NIH资助的HIV和次级预防艾滋病毒及其后的研究。
在Yerkes的Emory疫苗中心的免疫学核心生产了人类和非人类灵长类动物样品的多色细胞因子流式细胞仪染色面板。 该面板为调查人员提供了可观的资源节省,因为它更快,需要更少的样品和材料。 CFAR和EVC成员,包括Drs。艾哈迈德(Ahmed),阿玛拉(Amara),亨特(Hunter),维林格(Villinger)和外部实验室以及耶克斯国家灵长类动物研究中心(Yerkes National Pread)研究中心的使用者成功使用了该小组。 Yerkes的CFAR前病毒学核心,向研究员和研究生提供工具和测定开发培训和咨询,以促进和加速研究人员实验室的研究步伐。例如,核心为Colleen Kelley(ID研究员)提供了全方位服务的,实时的基于RT-PCR的基因表达分析和数据分析帮助,他们与Patrick Sullivan(Epidemiogist)合作,以扩大他的研究“解释HIV患病的差异和与男性发生性关系的白人和黑人男性之间的差异”(R01 MH0855600)。 核心的支持扩大了可用的研究主题,并将新的研究人员带入了艾滋病毒/艾滋病研究。
通过战略利用资金,CFAR协助招募了领先的高级和初级教师,并为许多CFAR和EVC相关的研究人员提供了必不可少的设备。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES W. CURRAN其他文献
JAMES W. CURRAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES W. CURRAN', 18)}}的其他基金
Predicting the Effect of Testing For and Treating HIV in Correctional Facilities
预测惩教设施中艾滋病毒检测和治疗的效果
- 批准号:
8134701 - 财政年份:2010
- 资助金额:
$ 17.84万 - 项目类别:
Infant Immunization to Reduce Pneumonia in HIV +ve women
婴儿免疫接种可减少艾滋病毒 ve 妇女的肺炎
- 批准号:
6778684 - 财政年份:2002
- 资助金额:
$ 17.84万 - 项目类别:
相似海外基金
Core D -Humanized Mouse and Gene Therapy Core
Core D - 人源化小鼠和基因治疗核心
- 批准号:
10458373 - 财政年份:2022
- 资助金额:
$ 17.84万 - 项目类别:
Stress keratin 17 and CD4/8 ratio as prognostic markers in HIV-related anogenital squamous cell precancers and cancers (Biospecimens/Biocohort)
应激角蛋白 17 和 CD4/8 比率作为 HIV 相关肛门生殖器鳞状细胞癌前病变和癌症的预后标志物 (Biospecimens/Biocohort)
- 批准号:
10620051 - 财政年份:2022
- 资助金额:
$ 17.84万 - 项目类别:
The 24th International AIDS Conference (AIDS 2022), 29 July-2 August 2022, Montreal, Canada and virtually
第 24 届国际艾滋病大会 (AIDS 2022),2022 年 7 月 29 日至 8 月 2 日,加拿大蒙特利尔
- 批准号:
10481133 - 财政年份:2022
- 资助金额:
$ 17.84万 - 项目类别:
Meharry HIV/AIDS Research and Training Facility
梅哈里艾滋病毒/艾滋病研究和培训设施
- 批准号:
10547968 - 财政年份:2022
- 资助金额:
$ 17.84万 - 项目类别: